Mitochondrial disease diagnosis
Learn about symptoms, tests, referrals, genetic diagnosis and the care pathway in the UK.
Learn about symptoms, tests, referrals, genetic diagnosis and the care pathway in the UK.
Living with unexplained and often debilitating symptoms can be frightening. The body’s inability to produce energy has a significant impact on health, wellbeing and quality of life in both children and adults, and it’s natural to wonder what’s going on. For some people, the answer is mitochondrial disease, often shortened to ‘mito’. Getting to that answer can take time, but there is a pathway and there’s support at every step. This page explains how mitochondrial disease is diagnosed in the UK.
If you’re early in the journey, you’re not alone. The Lily Foundation are here to support every patient, carer and loved one affected by a mitochondrial disease diagnosis.
Mitochondria are present inside almost all of our cells, turning food and oxygen into the energy your body needs. That energy powers everything, from your brain and heart to your muscles, hearing and digestion. When mitochondria don’t work properly, cells can struggle to produce energy, and that can lead to a condition called mitochondrial disease.
Mitochondrial disease (also called a primary mitochondrial disorder) is actually an umbrella term. It describes many different conditions that happen when the mitochondria in your cells can’t make enough energy. Symptoms can appear across multiple different systems in the body, especially affecting organs that require a lot of energy, such as the brain, heart or muscles.
When it comes to mitochondrial disease, everyone is affected differently, and two people with the same genetic change may have very different experiences. Some conditions appear in childhood, while others start in the teens or adulthood.
If you want a simple explainer to return to and share with family or your GP, our page on What is mitochondrial disease? is a good place to start.
Mitochondrial disorders can present at any age, but symptoms often differ between children and adults, reflecting how energy demand and organ involvement change across the lifespan. This variability is one of the reasons mitochondrial disease can be difficult to recognise and diagnose.
In children, mitochondrial disease often affects growth and development and may involve multiple organ systems from an early age. Symptoms may appear in infancy, early childhood or during periods of rapid development.
Common symptoms in children may include:
Because symptoms may evolve over time, some children are initially diagnosed with other neurological or metabolic conditions before mitochondrial disease is considered.
In adults, mitochondrial disorders often present more gradually and may initially affect a single system, although multiple systems can become involved over time. Symptoms may first appear in adolescence or adulthood, even if the underlying genetic change has been present since birth.
Common symptoms in adults may include:
Some adults experience relatively mild or non‑specific symptoms for many years, with many symptoms easily confused with other diseases or as a normal part of aging, which can delay referral for specialist assessment and genetic testing.
Clinicians often look for patterns rather than a single symptom, and certain patterns can prompt a referral. These include:
Having one or more of these symptoms is not an automatic diagnosis. If any of these sound familiar, keep a simple symptom diary and share it with your GP, along with family history and any previous test results. Ask whether features point to a possible mitochondrial disorder and, if so, request referral to a specialist clinic.
A GP or local community health team (e.g. paediatrician) is able to refer patients for further specialist testing based on their clinical symptoms, including for genetic testing which is freely available on the NHS. Depending on results, a patient may then be referred to a number of specialist teams depending on local provision and symptoms – this could be a neurologist, metabolic or neuromuscular team. From there a referral to one of the NHS Highly Specialised Services is recommended, so that patients can access the mitochondrial disease team and the research opportunities that this brings.
Diagnosis brings together clinical features and targeted investigations, with genetic testing now central to confirming a mitochondrial disorder diagnosis.
A specific genetic diagnosis is now central to diagnosis for mitochondrial disease. It can clarify prognosis, inform surveillance and treatment choices, guide eligibility for clinical trials and help families consider reproductive options. It also connects patients to the right research and support networks.
Gene panels targeting nuclear and mitochondrial DNA, and modern sequencing techniques including whole exome and whole genome sequencing, can identify the underlying variant in many patients. Mitochondrial DNA testing may be done in blood, urine or muscle.
In addition to genetic testing, doctors can use a range of other tests to help them diagnose mitochondrial disease.
You may not need all of the following, but here’s what’s commonly used:
Including medical history, family history and multi-system review.
Checking full blood count, lactate, creatine kinase, liver enzymes, glucose control, thyroid function and specific metabolites. Urine organic acids and amino acids can hint at energy pathway issues.
MRI of the brain can show patterns suggestive of mitochondrial disease, such as changes in the basal ganglia or stroke-like lesions that do not follow a typical blood vessel territory. Cardiac imaging and echocardiography may be used if heart involvement is suspected.
ECG and Holter monitoring for rhythm problems, audiology for hearing, ophthalmology for the retina and optic nerve, and exercise testing in selected cases.
Less common than it used to be, but still important in some scenarios. A small sample is examined for characteristic changes, enzyme activities and mitochondrial DNA content. Biopsy is considered when genetic testing is inconclusive or when tissue analysis will guide management.
The Lily Foundation invests in diagnostic innovation to complement NHS pathways. Our Precision Medicine Diagnostics project supports deeper analysis and reanalysis of genetic data using modern tools. This helps identify variants missed initially and can open doors to research studies and tailored care.
This programme doesn’t replace NHS services – it sits alongside them, helping to close gaps, shorten the diagnostic odyssey and get families to answers sooner.
A precise diagnosis does more than put a name to symptoms. It can:
If you’re thinking about exploring reproductive choices, you can read more about mitochondrial reproductive options and we’d also encourage you to speak with your genetics team.
In the UK, diagnosis is typically led by a consultant neurologist, clinical geneticist or metabolic physician within an NHS Rare Mitochondrial Disorders Service. Paediatricians with expertise in rare diseases are central for children. These teams work together, often with cardiology, ophthalmology, audiology and physiotherapy, to build a complete picture and plan care.
Finding the exact genetic cause that confirms a person’s mitochondrial disease can be extremely challenging, and some people wait many months to years for scientists to identify theirs. The diagnostic odyssey has been compared to looking for a needle in a haystack or a single spelling mistake in an entire dictionary. Identifying the precise genetic change requires multiple specialist techniques and iterative testing, which is why it can often be a lengthy process.
There are simple high street tests that claim to assess mitochondrial health and function. However, there’s no reliable over-the-counter test that can genetically diagnose mitochondrial disease, and there’s no evidence to recommend the use of these tests. Proper diagnosis combines clinical evaluation, laboratory tests and genetic analysis in a specialist setting.
A diagnosis of mitochondrial disease can bring clarity after a long diagnostic journey, but it often raises new questions about treatment, prognosis and day‑to‑day management. While there is currently no cure for mitochondrial disease, a confirmed diagnosis plays a crucial role in guiding care, monitoring health and offering support to individuals and families.
Following diagnosis, care is usually coordinated by a multidisciplinary specialist team, which may include neurologists, geneticists, metabolic specialists, cardiologists and other professionals depending on the organs affected.
Management is tailored to the individual and may include:
The aim is to optimise quality of life, maintain function and reduce complications rather than treat the underlying genetic cause.
Because mitochondrial disease can affect multiple organ systems and may change over time, regular monitoring is an important part of care. This can include:
Surveillance allows potential complications to be identified early, even if symptoms aren’t yet obvious.
A confirmed diagnosis often leads to referral for genetic counselling, which helps individuals and families understand:
In some cases, additional testing may be offered to relatives, a process known as cascade testing.
Even after diagnosis, there may be unanswered questions about how the condition will progress. Mitochondrial disease is highly variable, and predicting outcomes can be difficult. Ongoing follow‑up with specialist teams allows care plans to adapt as needs change.
After diagnosis, many people benefit from connecting with:
These resources can provide practical advice, emotional support and up‑to‑date information about research and clinical trials.
Here at The Lily Foundation, we understand the strength and power of community in helping to support patients and families facing a mitochondrial disease diagnosis.
Whether you’re a patient, parent, sibling or friend, we’re here to provide comprehensive mitochondrial disease support. Our resources and services are designed to help you manage the emotional, physical and practical aspects of a mitochondrial disorder, with a focus on improving quality of life.
If you’ve been diagnosed with mitochondrial disease and need to talk to someone, we’re here to listen. You can contact Liz by calling 0300 400 1234 or emailing [email protected]. Feel free to get in touch if you’re caring for someone with suspected or confirmed mitochondrial disease too.
We’re also available through our social media channels, where we closely monitor messages to respond as quickly as possible. Many members of The Lily Foundation team have direct experience with mitochondrial disease, which makes a meaningful difference in the support we can provide to families.
Finally, we’re proud to partner with Rareminds to offer a free, confidential counselling service for patients and family members aged 18+ who have been impacted by a mitochondrial disease diagnosis. This specialised support service is designed to help you navigate the emotional challenges that come with living with mitochondrial disease.
If you’re looking for reliable information to share with your GP, explore our resources for healthcare professionals. For medicine safety questions, visit our mitochondrial disease drug information page. And if today feels heavy, please get in touch. The Lily Foundation are here to provide practical advice, emotional support and a community that understands – because no one has to face mito alone.
Through a combination of clinical assessment, targeted blood and urine tests, imaging, sometimes muscle biopsy, and modern genetic testing. In the UK this is co-ordinated by specialist NHS services.
Commonly lactate and metabolic profiles, MRI, cardiac and hearing assessments, and genetic testing of mitochondrial DNA and nuclear genes. A muscle biopsy is considered when indicated.
There’s no single consumer test. Clinicians assess mitochondrial function indirectly through clinical features, lab markers, imaging and, where appropriate, tissue studies and genetics.
Unexplained fatigue and muscle weakness, seizures or stroke-like episodes, developmental delay or regression, hearing or vision loss, and multi-system symptoms occurring together.
Autoimmune and inflammatory diseases, other metabolic disorders, muscular dystrophies, thyroid problems, neuropathies and the effects of certain medications.
Neurologists, clinical geneticists and metabolic physicians within NHS specialist mitochondrial services, often in a multidisciplinary team.
Yes. Mitochondrial disease can be missed or misdiagnosed, especially when symptoms are mild, non‑specific or affect only one organ system. Routine tests may appear normal, and symptoms often overlap with more common neurological, metabolic or autoimmune conditions. Specialist assessment is often needed to recognise underlying mitochondrial disease.
Many people with mitochondrial disease have normal routine tests. Specialist investigations are often needed.
Most mitochondrial diseases are genetic, but inheritance patterns vary. Some are inherited through the mitochondrial DNA (usually maternal), others through nuclear genes following autosomal recessive or dominant patterns. In some cases, a genetic change arises for the first time in an individual with no family history. Read more about understanding inheritance patterns in mitochondrial disease over in our Research Zone.
Yes. Many people are diagnosed in adolescence or adulthood, even if the genetic change has been present since birth. Adult‑onset mitochondrial disease often develops gradually and may initially cause fatigue, muscle weakness or neurological symptoms, which can delay referral for specialist testing and diagnosis.
Our new guide will help you make sense of your condition. Find easy-to-understand explainers, science simplified and the reassurance that we’re with you every step of the way.
If you have any problems please email [email protected]